Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
09:33am, Tuesday, 14'th Jun 2022 Benzinga
Alopecia areata, an autoimmune disorder that causes patchy hair loss, now has a new treatment that has been approved by the Food and Drug Administration.
Eli Lilly & Company (NYSE: LLY) and Incyte Cor
Eli Lilly (LLY) Stock Moves -1.93%: What You Should Know
09:45pm, Monday, 13'th Jun 2022 Zacks Investment Research
Eli Lilly (LLY) closed the most recent trading day at $291.28, moving -1.93% from the previous trading session.
Most Active Stocks Today? 5 Defensive Stocks For Your Watchlist
12:15pm, Monday, 13'th Jun 2022
Are defensive stocks the right move amid soaring inflation?
Is Invesco Dynamic Large Cap Growth ETF (PWB) a Strong ETF Right Now?
10:20am, Monday, 13'th Jun 2022 Zacks Investment Research
Smart Beta ETF report for PWB
6 Stocks Moved By Traders On 'Fast Money Halftime Report'
06:00pm, Thursday, 09'th Jun 2022 Benzinga
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors.
The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refine
Rigel (RIGL) wAIHA Study Fails to Meet Goals, Stock Tanks
04:48pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Rigel (RIGL) phase III study evaluating fostamatinib in patients with warm autoimmune hemolytic anemia did not demonstrate statistical significance in the primary efficacy endpoint.
Final Trades: ChargePoint, Eli Lilly, Sabra Health Care & more
01:52pm, Thursday, 09'th Jun 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
09:50pm, Wednesday, 08'th Jun 2022 Zacks Investment Research
Eli Lilly (LLY) closed at $313.49 in the latest trading session, marking a +0.45% move from the prior day.
Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
02:30pm, Wednesday, 08'th Jun 2022
Three weeks ago, I suggested that the severe correction in biopharmaceutical stocks had ended. I expect the bottoming process to be choppy with a bias to the upside. The antecedent cause of the declin
Lilly (LLY) Eczema Candidate Keeps Skin Clearance for One Year
07:25pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Data from late-stage studies conducted by Eli Lilly (LLY) shows that its atopic dermatitis drug maintained improvement in skin clearance and itch relief in 8 of 10 patients for a one-year treatment.
Lilly (LLY) Eczema Candidate Keeps Skin Clearance for One Year
04:33pm, Tuesday, 07'th Jun 2022
Data from late-stage studies conducted by Eli Lilly (LLY) shows that its atopic dermatitis drug maintained improvement in skin clearance and itch relief in 8 of 10 patients for a one-year treatment.
4 Top Dividend Stocks To Watch In The Stock Market Today
04:30pm, Tuesday, 07'th Jun 2022
Check these dividend stocks out for your watchlist right now.
Eli Lilly weight loss drug for type-2 diabetes approved by the FDA
04:12pm, Tuesday, 07'th Jun 2022
Yahoo Finance senior health reporter Anjalee Khemlani details Eli Lilly's type-2 diabetes drug approval by the FDA for use as a weight loss drug.
Eli Lilly and Company (NYSE:LLY ) 82nd Scientific Sessions of the American Diabetes Association conference June 7, 2022 11:30 AM ET Company Participants Lauren Zierke - Senior Director of Investor Rel
Company News for Jun 7, 2022
01:36pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Companies in The News Are: SIAC,LLY,SEDG,SAVE,JBLU
